Contribution of LCMV transgenic models to understanding T lymphocyte development, activation, tolerance, and autoimmunity.
Nguyen
L T
LT
Department of Immunology, Ontario Cancer Institute, 610 University Avenue, Toronto, Ontario, Canada, M5G 2M9.
Bachmann
M F
MF
Ohashi
P S
PS
D000818:Animals; D015551:Autoimmunity; D004195:Disease Models, Animal; D006801:Humans; D007108:Immune Tolerance; D008213:Lymphocyte Activation; D008217:Lymphocytic choriomeningitis virus / Q000276:immunology* / Q000378:metabolism; D051379:Mice; D008822:Mice, Transgenic; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000235:genetics / Q000378:metabolism*; D013601:T-Lymphocytes / Q000276:immunology* / Q000502:physiology; D019076:Transgenes
D016693:Receptors, Antigen, T-Cell, alpha-beta